<DOC>
	<DOCNO>NCT01282593</DOCNO>
	<brief_summary>Down regulation CD9 TEL/AML1-positive ALL address motility assay explore role B-ALL pathogenesis potential implication relapse ( prognosis ) .</brief_summary>
	<brief_title>Potential Role CD9 Implication Motility Process Pathogenesis TEL/ALM1-positive ALL Relapses ( LAL TEL/ALM1 CD9 ) .</brief_title>
	<detailed_description>1 . Assess impact CD9 expression level motility assay ( migration adhesion ) We initiate motility assay ( fibronectin adhesion experiment CXCL12 chemoattracted migration test modify Boyden chamber technique ) use CD9 positive TEL/AML1-positive cell line REH CD9 negative cell line RAJI ( wild transfected CD9 cDNA ) . Data analyze combination block antibody chemical antagonist accord level CD9 ( transcript protein ) CXCR4 . Protein quantification perform flow cytometry Western Blot . Interactions explore confocal microscopy biological pathway immunoblot . Adhesion result validate patient sample B-ALL . 2 . Post-transcriptional regulation CD9 TEL/AML1-positive ALL To identify miRNAs potentially deregulate TEL/AML1-positive acute lymphoblastic leukaemia especially screen CD9 -targeted miRNAs , use TaqMan ®MicroRNA Arrays approach allow simultaneous measurement 760 human miRNA . Small RNA extract bone marrow sample twenty childhood B-ALL screen miRNAs differentially express CD9-positive CD9-negative ALL compare miRNAs predict target CD9 databases . Validation selection perform single Q-PCR select miRNAs use novel cohort ten bone marrow sample . Transfection assay luciferase assay realize confirm differential miRNAs really target affect CD9 expression .</detailed_description>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>patient &gt; 1 year ≤18 year BALL diagnosis register Rennes treatment write informed consent sign patient parent legal guardian Refusal participate Inherited cytogenetic abnormality</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>TEL/ALM1_positive ALL relapse</keyword>
</DOC>